Trial intelligence / Profile preview

TAP Blocks for Inguinal Hernia Repairs

NCT05672680Phase 3Completed

Sponsor
Icahn School of Medicine at Mount Sinai
Start
Dec 2019
Primary completion
Aug 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of bupivacaine in postoperative pain, sponsored by Icahn School of Medicine at Mount Sinai. Started Dec 2019; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05672680.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05672680.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call